Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
about
Replication of SULT4A1-1 as a pharmacogenetic marker of olanzapine response and evidence of lower weight gain in the high response group.Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trialGenotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.Pharmacogenetics of second-generation antipsychotics.
P2860
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@ast
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@en
type
label
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@ast
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@en
prefLabel
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@ast
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@en
P2093
P2860
P356
P1433
P1476
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
@en
P2093
Calvin Patrick
Maidar Jamba
Mark D Brennan
Saranya Padmanabhan
P2860
P304
P356
10.2217/PGS.12.105
P577
2012-08-01T00:00:00Z